XML 77 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Details) (USD $)
3 Months Ended 12 Months Ended
Sep. 30, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Tax Contingency [Line Items]          
Deferred tax assets   $ 9,395,000 $ 13,881,000 $ 9,395,000  
Deferred tax assets   78,441,000 46,625,000 78,441,000  
Current:          
Federal     (2,492,000) (1,299,000) (1,380,000)
State     (1,309,000) (1,677,000) (1,433,000)
Foreign     (863,000) (226,000) 0
Total     (4,664,000) (3,202,000) (2,813,000)
Deferred:          
Federal     (26,388,000) 48,384,000 43,582,000
State     (3,920,000) 5,077,000 (282,000)
Foreign     (66,000) (225,000) 0
Deferred income tax expense (benefit)     30,374,000 (53,236,000) (43,300,000)
Benefit (provision) for income taxes     35,038,000 (50,034,000) (40,487,000)
Components of Income (Loss) Before Income Taxes          
Domestic     92,998,000 84,390,000 80,765,000
International     (6,790,000) (6,547,000) (16,617,000)
Income before income taxes     86,208,000 77,843,000 64,148,000
Statutory federal income tax rate     35.00% 35.00% 35.00%
Tax Rate Reconciliation [Abstract]          
Statutory rate applied to pre-tax income (loss)     30,202,000 27,245,000 22,452,000
State income taxes, net of federal benefit     3,399,000 (2,210,000) 1,115,000
Foreign     2,136,000 (1,263,000) 1,551,000
Tax exempt portion of WilmerHale settlement     0 (4,344,000) 0
Revaluation of Targanta conversion rights     (511,000) (1,735,000) 602,000
Tax credits     (1,712,000) (1,000,000) 0
Lobbying costs     171,000 0 1,324,000
Meals and entertainment     386,000 349,000 390,000
Uncertain tax positions     542,000 0 510,000
Other     425,000 (567,000) 181,000
Net operating loss utilization     0 0 (23,438,000)
(Decrease) increase to federal valuation allowances     0 (66,509,000) (45,174,000)
Income tax (benefit) provision     35,038,000 (50,034,000) (40,487,000)
Deferred tax assets:          
Net operating loss carryforwards   32,437,000 23,501,000 32,437,000  
Tax credits   24,072,000 13,581,000 24,072,000  
Intangible assets   23,352,000 17,760,000 23,352,000  
Stock based compensation   15,692,000 16,994,000 15,692,000  
Other   14,841,000 10,386,000 14,841,000  
Total deferred tax assets   110,394,000 82,222,000 110,394,000  
Valuation allowance   (4,190,000) (2,425,000) (4,190,000)  
Total deferred tax assets net of valuation allowance   106,204,000 79,797,000 106,204,000  
Deferred tax liabilities:          
Fixed assets   (979,000) (1,192,000) (979,000)  
Indefinite lived intangible assets   (17,389,000) (18,099,000) (17,389,000)  
Total deferred tax liabilities   (18,368,000) (19,291,000) (18,368,000)  
Net deferred tax assets   87,836,000 60,506,000 87,836,000  
Deferred tax asset valuation allowance   4,200,000 2,400,000 4,200,000  
Change in valuation allowance against deferred tax assets (66,500,000) (66,500,000)      
Eliminated deferred tax assets (500,000)     (22,100,000)  
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]          
Gross unrecognized tax benefits, beginning of period     1,891,000 1,891,000  
Additions related to current year tax positions     0 0  
Additions for prior year tax positions     542,000 0  
Reductions for prior year tax positions     0 0  
Settlements     0 0  
Gross unrecognized tax benefits, ending of period   1,891,000 2,433,000 1,891,000 1,891,000
Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     8,529,000    
Federal Net Operating Loss [Member]
         
Deferred tax liabilities:          
Tax carryforwards     60,217,000    
Alternative Minimum Tax Credit [Member]
         
Deferred tax liabilities:          
Additional tax carryforwards     4,900,000    
Foreign Net Operating Losses [Member]
         
Deferred tax liabilities:          
Tax carryforwards     15,100,000    
Year of Expiration 2018 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     0    
Year of Expiration 2025 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     224,000    
Year of Expiration 2026 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     1,971,000    
Year of Expiration 2026 [Member] | Federal Net Operating Loss [Member]
         
Deferred tax liabilities:          
Tax carryforwards     0    
Year of Expiration 2027 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     1,028,000    
Year of Expiration 2027 [Member] | Federal Net Operating Loss [Member]
         
Deferred tax liabilities:          
Tax carryforwards     16,507,000    
Year of Expiration 2028 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     1,186,000    
Year of Expiration 2028 [Member] | Federal Net Operating Loss [Member]
         
Deferred tax liabilities:          
Tax carryforwards     38,955,000    
Year of Expiration 2029 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     899,000    
Year of Expiration 2029 [Member] | Federal Net Operating Loss [Member]
         
Deferred tax liabilities:          
Tax carryforwards     4,755,000    
Year of Expiration 2030 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     1,051,000    
Year of Expiration 2031 [Member] | Federal Research and Development Tax Credit [Member]
         
Deferred tax liabilities:          
Tax carryforwards     $ 2,170,000